AwardTape · Defense awards · Research and development · Defense systems R&D · FA864922P1073
FA864922P1073: $0 purchase order to Omnisync Incorporated
Omnisync Incorporated holds a purchase order from Department of the Air Force with $0 obligated since Oct 2023 and $757K obligated over its life, against a ceiling of $757K. Latest action Oct 27, 2023.
Automated requirements package creation software for resource advisors and contracting officers to streamline contracting processes within the us air force
| PIID | FA864922P1073 |
|---|---|
| Type | purchase order |
| Company | Omnisync Incorporated |
| Agency | Department of the Air Force |
| Contracting office | FA8649 USAF SBIR STTR CNTRCTNG AFRL |
| Category | Research and development · Defense systems R&D |
| PSC | AC32 NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $757K |
| Ceiling (base and all options) | $757K |
| Base date | Jul 28, 2022 |
| Latest action | Oct 27, 2023 |
| End date | Oct 27, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | CA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial